DRUG-THERAPY - DRUGS AND SURGERY IN THE PREVENTION OF ISCHEMIC STROKE

被引:173
作者
BARNETT, HJM
ELIASZIW, M
MELDRUM, HE
机构
[1] UNIV WESTERN ONTARIO, DEPT CLIN NEUROL SCI, LONDON, ON, CANADA
[2] UNIV WESTERN ONTARIO, DEPT EPIDEMIOL & BIOSTAT, LONDON, ON, CANADA
关键词
D O I
10.1056/NEJM199501263320408
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ischemic and hemorrhagic strokes are among the principal causes of death and disability in older people, although the incidence of such strokes is lower than in the past.1,2 Control of blood pressure, decreased cigarette smoking, and possibly altered dietary habits are among the important but unconfirmed reasons proposed for this decline.3–5 This review addresses the antithrombotic and surgical measures to prevent ischemic stroke that have been rigorously evaluated in randomized clinical trials. Use of Anticoagulant Agents to Prevent Ischemic Stroke Since the introduction of anticoagulant agents 50 years ago, their use has varied widely, which is to be.  . . © 1995, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:238 / 248
页数:11
相关论文
共 112 条
  • [1] CONTROLLED TRIAL OF DIPYRIDAMOLE IN CEREBRAL VASCULAR DISEASE
    ACHESON, J
    DANTA, G
    HUTCHINSON, EC
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1969, 1 (5644): : 614 - +
  • [2] ACKERMAN RH, 1990, ANN NEUROL, V28, P224
  • [3] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [4] PREDICTORS OF THROMBOEMBOLISM IN ATRIAL-FIBRILLATION .1. CLINICAL-FEATURES OF PATIENTS AT RISK
    ANDERSON, DC
    ASINGER, RW
    NEWBURG, SM
    FARMER, CC
    WANG, K
    BUNDLIE, SR
    KOLLER, RL
    JAGIELLA, WM
    KREHER, S
    JORGENSEN, CR
    SHARKEY, SW
    FLAKER, GC
    WEBEL, R
    NOLTE, B
    STEVENSON, P
    BYER, J
    WRIGHT, W
    CHESEBRO, JH
    WIEBERS, DO
    HOLLAND, AE
    MILLER, DM
    BARDSLEY, WT
    LITIN, SC
    MEISSNER, I
    ZERBE, DM
    MCANULTY, JH
    MARCHANT, C
    COULL, BM
    FELDMAN, G
    HAYWARD, A
    GANDARA, E
    MACMILLAN, K
    BLANK, N
    LEONARD, AD
    KANTER, MC
    ISENSEE, LM
    QUIROGA, ES
    PRESTI, CH
    TEGELER, CH
    LOGAN, WR
    HAMILTON, WP
    GREEN, BJ
    BACON, RS
    REDD, RM
    CADELL, DJ
    GOMEZ, CR
    JANOSIK, DL
    LABOVITZ, AJ
    KELLEY, RE
    CHAHINE, R
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) : 1 - 5
  • [5] [Anonymous], 1989, Stroke, V20, P844
  • [6] [Anonymous], 1990, Stroke, V21, P1122
  • [7] [Anonymous], 1985, Stroke, V16, P406
  • [8] [Anonymous], 1988, BRIT MED J, V296, P320
  • [9] [Anonymous], 1994, Lancet, V343, P499
  • [10] [Anonymous], 1991, Lancet, V338, P1345